Navigation Links
Isis Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study
Date:12/3/2008

CARLSBAD, Calif., Dec. 3 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) announced today that OncoGenex Pharmaceuticals, Inc. provided positive survival results from a randomized Phase 2 clinical trial of OGX-011 in combination with docetaxel and prednisone ("the OGX-011 arm") compared to docetaxel and prednisone alone ("the control arm") for first-line treatment of metastatic castrate resistant prostate cancer. The current 10.6 month median overall survival advantage observed in the OGX-011 arm represents an increase over the median survival observed in the control arm. OGX-011 was jointly discovered by Isis and the initial development was conducted by Isis and OncoGenex. OGX-011 is now being developed by OncoGenex.

"The progress our partners are making with antisense drugs discovered using Isis' antisense technology demonstrates the value of our technology to create drugs that are first-in-class and may provide new treatment options in a broad range of diseases, including cancer," said Stanley Crooke, Chairman and Chief Executive Officer of Isis. "We are encouraged by the latest results from OGX-011 and look forward to OncoGenex announcing the full results of the study next year."

According to OncoGenex' announcement, the Phase 2 randomized study in 82 patients with metastatic or locally recurring prostate cancer refractory to hormone therapy showed a median survival of 27.5 months for the patients in the OGX-011 arm and 16.9 months for patients in the control arm. Results currently indicate that patients in the OGX-011 arm have a death rate approximately 40% lower than patients in the control arm. The current results were based on study data with a median follow-up of approximately 30 months for both arms. OncoGenex indicates that additional survival updates will be needed before mature me
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... July 28, 2015 Isis Pharmaceuticals, Inc. (NASDAQ: ... a live webcast on Tuesday, August 4 at 11:30 ... financial results and report on pipeline and business progress.  ... call by dialing 877-443-5662 or access the webcast at ... for a limited time at the same address. ...
(Date:7/28/2015)... SOUTH SAN FRANCISCO, Calif. , July 28, ... ) today announced that it will report its ... Tuesday, August 4, 2015.  Rigel senior management will ... and webcast at 4:30pm Eastern Time (1:30pm Pacific ... Participants can access the live conference call by ...
(Date:7/27/2015)... 2015 CTI BioPharma Corp. (NASDAQ and MTA: ... second quarter 2015 financial results on Thursday, August 6, ... Following the announcement, members of the management team will ... and provide a general corporate update at 4:30 p.m. ... be obtained as follows: Thursday, August 6 ...
Breaking Medicine Technology:Webcast Alert: Isis Pharmaceuticals' Second Quarter 2015 Financial Results Conference Call 2Webcast Alert: Isis Pharmaceuticals' Second Quarter 2015 Financial Results Conference Call 3Rigel Announces Conference Call and Webcast to Report Second Quarter 2015 Financial Results 2CTI BioPharma to Report Second Quarter 2015 Financial Results on August 6, 2015 2
... Aug. 18, 2011 A national analysis conducted ... North America, Inc., identified Columbus, Ohio, as one ... that have hypertension risk factors and complications. The ... of a larger Takeda-sponsored hypertension awareness program called ...
... 18, 2011 Reportlinker.com announces that a ... its catalogue: China ... http://www.reportlinker.com/p0590608/China-Contract-Research-Organization-CRO-Industry-Report-2010-2011.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Disc ... high R&D costs of new drugs worldwide, ...
Cached Medicine Technology:Columbus Included in Analysis of Top Hypertension Hot Spots in the United States 2Columbus Included in Analysis of Top Hypertension Hot Spots in the United States 3Columbus Included in Analysis of Top Hypertension Hot Spots in the United States 4China Contract Research Organization (CRO) Industry Report, 2010-2011 2China Contract Research Organization (CRO) Industry Report, 2010-2011 3China Contract Research Organization (CRO) Industry Report, 2010-2011 4China Contract Research Organization (CRO) Industry Report, 2010-2011 5
(Date:7/28/2015)... ... July 28, 2015 , ... A ... shipbreaking workers than they are in the general population. Surviving Mesothelioma has just ... now. , Researchers at Taiwan’s National Health Research Institutes and three Taiwanese ...
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... Fertility ... chosen as a “Top Doctor 2015” by Atlanta Magazine. In Atlanta Magazine's annual Top ... by hundreds of her esteemed colleagues and peers in the metro area as one ...
(Date:7/28/2015)... ... July 28, 2015 , ... ... Breakdown of Mets' David Wright's Spinal Stenosis Injury" discussed baseball player David Wright’s ... stenosis is acquired lumbar stenosis, brought on by degenerative changes in the spine, ...
(Date:7/28/2015)... Mountain View, CA (PRWEB) , ... July 28, ... ... Organic Coconut Water line has won the 2015 NCW Eco-Excellence Award for the ... adult, child and pet lifestyle industries and elevate companies that stand out for ...
(Date:7/28/2015)... Myers, Florida (PRWEB) , ... July 28, 2015 ... ... Ltd., America's trusted source for identifying Top Doctors, has based its selection process ... are the most outstanding in their medical specialties, in any area of medicine ...
Breaking Medicine News(10 mins):Health News:New Findings Suggest Mesothelioma is Not the Only Cancer Threat for Shipbreakers, According to Surviving Mesothelioma 2Health News:Atlanta Fertility Specialist Named Top Doctor in Atlanta Magazine 2Health News:Atlanta Fertility Specialist Named Top Doctor in Atlanta Magazine 3Health News:Spine Surgeon Weighs in on Uncertain Future Baseball Career Future for David Wright 2Health News:Spine Surgeon Weighs in on Uncertain Future Baseball Career Future for David Wright 3Health News:Coco Libre Wins 2015 NCW Eco-Excellence Award 2Health News:Fort Myers Plastic Surgeon Recognized as One of the America’s “Top Doctors®” by Prestigious Castle Connolly Medical Ltd. for 5 Years in a Row 2Health News:Fort Myers Plastic Surgeon Recognized as One of the America’s “Top Doctors®” by Prestigious Castle Connolly Medical Ltd. for 5 Years in a Row 3
... supports the theory that bringing about senescence in aged ... ,Inducing senescence in aged cells may be sufficient to ... published online this week in European Molecular Biology Organization ... or programmed cell death – apoptosis – was the ...
... be sufficient to guard against spontaneous cancer development, ... in EMBO reports//. It was previously unknown whether ... – was the more important safeguard mechanism for ... cells have abnormal chromosomes with dysfunctional telomeres – ...
... dead due to the infection of a hospital superbug at ... Clostridium Difficile, commonly known as C diff, within the last ... of the patients were infected with a virulent strain of ... had to be performed on five other patients who had ...
... much of the molecular machinery required for life, are ... all proteins are membrane proteins – embedded within the ... the other two-thirds using such tools as antibodies, they ... portions of proteins. ,To probe the secrets ...
... at the University of Alabama at Birmingham's Magnetic Source ... , using MEG (magneto-encephalography) scanners to learn more about ... types of brain scans detail the geography of the ... the magnetic signals that neurons throw off as they ...
... -- Researchers have identified the receptor pathway used by ... The related report by Hsieh et al, “G protein-coupled ... nongenomic effects of estrogen in attenuating liver injury after ... Journal of Pathology and is accompanied by a commentary. ...
Cached Medicine News:Health News:Penn Scientists Engineer Small Molecules to Probe Proteins Deep Inside Cell Membrane 2Health News:MEG Scanners Are Mega Powerful 2Health News:Estrogen Protects Liver After Traumatic Injury 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: